The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
Previous Story
Jon Stewart Signs Extension for ‘Daily Show’ Through 2026
Next Story
Starbucks to Sell 60% of Its China Business to a Private Equity Firm
